09:57 FE PHARMA TECH<00399> - Announcement The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. FAR EAST PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED (Incorporated in the Cayman Islands with limited liability) (Provisional Liquidators Appointed) (Stock Code: 399) Petition for Winding Up Appointment of Provisional Liquidators Adjournment of Hearing of Winding-Up Petition (1) On 15 September 2004 a petition to wind up the Company was presented by Standard Chartered Bank (Hong Kong) Limited in the High Court of Hong Kong. (2) Messrs. Lai Kar Yan Derek and Darach E. Haughey of Deloitte Touche Tohmatsu were appointed joint and several provisional liquidators of the Company by the High Court of Hong Kong on 22 September 2004. (3) On 25 October 2004 the hearing of the winding-up petition against the Company was adjourned to 28 February 2005 on which day the adjourned hearing of the winding-up petition was further adjourned to 27 June 2005. Trading in the shares of the Company has been suspended since 17 June 2004 and will remain suspended until further notice. Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) (the "Company") announces that: (1) A petition to wind up the Company (the "Petition") was presented by Standard Chartered Bank (Hong Kong) Limited (the "Petitioner") on 15 September 2004 as the Company could not meet demands made against the Company for the repayment of outstanding principal and unpaid interest in relation to the Syndicated Bank Loan, totaling US$57,764,588.23 as at 9 September 2004, referred to in the Company's announcement dated 20 September 2004. (2) Messrs Lai Kar Yan Derek and Darach E. Haughey of Deloitte Touche Tohmatsu were appointed joint and several provisional liquidators of the Company pursuant to an order dated 22 September 2004 made by the Honourable Madam Justice Kwan (the "Court Order"). The Provisional Liquidators are empowered, inter alia, to take possession of the property of the Company and its subsidiaries, to consider and if thought to be in the interests of creditors and shareholders of the Company, to draft, with a view to implementing, a scheme of arrangement to be entered into between the Company and its creditors and to do all things necessary to facilitate such actions. (3) The hearing on 25 October 2004 of the winding-up petition presented against the Company by Standard Chartered Bank (Hong Kong) Limited was ordered by the High Court of Hong Kong to be adjourned to 28 February 2005. The adjourned hearing of the winding-up petition against the Company held on 28 February 2005 was ordered by the High Court of Hong Kong to be further adjourned to 27 June 2005. The Company will keep the public informed by making further announcements as appropriate. Please note that this announcement is only released on the AMS/3 Trading Terminal and the website of The Stock Exchange of Hong Kong Limited and has not been published in the newspapers as required by the Listing Rules due to the liquidity problem of the Company. As at the date of this announcement, the Board of Directors of the Company consists of two independent non-executive directors, namely Mr. Chiu Koon Shou, Victor, and Mr. Lo Wah Wai, Lowell. Trading in the shares of the Company has been suspended since 17 June 2004 and will remain suspended until further notice. For and on behalf of Far East Pharmaceutical Technology Company Limited (Provisional Liquidators Appointed) Darach E. Haughey Joint and Several Provisional Liquidator Hong Kong, 17 March 2005